Education
About Us
Working with TipRanks
Follow Us
SAGE Therapeutics (CH:SG7)
:SG7
SG7 Analyst Ratings
Hold
2 Buy
11 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SG7 Stock 12 Month Forecast
Average Price Target
CHF7.32
| Highest Price TargetCHF10.04 | Average Price TargetCHF7.32 | Lowest Price TargetCHF4.18 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Best Analysts Covering SAGE Therapeutics
Which Analyst Should I Follow If I Want to Buy CH:SG7 and Sell After:
1 Month
xxx
Success Rate
11/19 ratings generated profit
Average Return
-0.11%
reiterated a xxx
rating yesterday
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 57.89% of your transactions generating a profit, with an average return of -0.11% per trade.
3 Months
xxx
Success Rate
13/19 ratings generated profit
Average Return
+2.28%
reiterated a xxx
rating yesterday
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +2.28% per trade.
1 Year
Success Rate
9/19 ratings generated profit
Average Return
-6.93%
reiterated a sell rating yesterday
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 47.37% of your transactions generating a profit, with an average return of -6.93% per trade.
2 Years
xxx
Success Rate
6/19 ratings generated profit
Average Return
-21.56%
reiterated a xxx
rating yesterday
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 31.58% of your transactions generating a profit, with an average return of -21.56% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SG7 Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
3
3
3
2
1
Buy
1
1
1
1
1
Hold
20
21
19
23
14
Sell
1
0
1
1
1
Strong Sell
0
0
0
0
0
total
25
25
24
27
17
Each month's total comprises the sum of three months' worth of ratings.
SG7 Financial Forecast
SG7 Stock Forecast FAQ
What is CH:SG7’s average 12-month price target, according to analysts?
Based on analyst ratings, SAGE Therapeutics’s 12-month average price target is 7.32.
What is CH:SG7’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:SG7, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SAGE Therapeutics a Buy, Sell or Hold?
SAGE Therapeutics has a consensus rating of Hold, which is based on 2 buy ratings, 11 hold ratings and 1 sell ratings.
What is SAGE Therapeutics’s share price target?
The average share price target for SAGE Therapeutics is 7.32. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF10.04 ,and the lowest forecast is CHF4.18. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is CHF10.04 ,and the lowest forecast is CHF4.18. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about SAGE Therapeutics?
SAGE Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of SAGE Therapeutics?
To buy shares of CH:SG7, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.